SCHEDULE: Vanguard Amends Alector Stake, Reports 6.32% Ownership

The Vanguard Group has filed an amended Schedule 13G, disclosing a 6.32% beneficial ownership stake in Alector Inc. as of December 31, 2025.

Summary

• The Vanguard Group reported beneficial ownership of 6,908,054 shares of Alector Inc. common stock.
• This represents 6.32% of Alector Inc.'s outstanding common stock.
• Vanguard holds shared voting power over 605,402 shares and shared dispositive power over 6,908,054 shares.
• An internal realignment occurred on January 12, 2026, where The Vanguard Group, Inc. ceased performing portfolio management services or administering proxy voting.
• Following the realignment, certain subsidiaries or business divisions of Vanguard are expected to report beneficial ownership separately (on a disaggregated basis).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a largely neutral filing, as it primarily reports a factual ownership stake. The continued significant holding by a major institutional investor like Vanguard can be seen as a minor positive signal of long-term confidence, though it's likely part of a passive investment strategy.

Positives

• A major institutional investor, The Vanguard Group, maintains a significant 6.32% stake in Alector Inc., indicating continued investment interest.
• The filing clarifies future reporting structure for Vanguard's holdings, potentially increasing transparency for specific fund ownership.

Negatives

• The filing itself does not present negative information regarding Alector Inc.'s performance or outlook.
• The internal realignment at Vanguard means future beneficial ownership reporting will be disaggregated, which might require investors to track multiple filings to understand the full Vanguard-affiliated stake.

Risks

• The filing does not detail specific risks related to Alector Inc.'s operations or financial health; it is an ownership disclosure.

Future Outlook

The Vanguard Group, Inc. anticipates that following an internal realignment on January 12, 2026, certain subsidiaries or business divisions will report beneficial ownership separately (on a disaggregated basis) in reliance on SEC Release No. 34-39538. These subsidiaries will pursue the same investment strategies as previously.

Management Comments

• The Vanguard Group, Inc. anticipates that certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that currently have, or are deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release.
• These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that The Vanguard Group is one of the world's largest investment management companies, and its significant stake in Alector Inc. reflects a typical passive investment strategy through its various funds. The internal realignment and subsequent disaggregated reporting by its subsidiaries align with common practices for large, diversified asset managers to comply with regulatory requirements while maintaining operational efficiency across their diverse investment vehicles.

Comparison to Industry Standards

• This filing is a standard Schedule 13G amendment, reporting beneficial ownership by a large institutional investor. It does not contain performance data for Alector Inc. that would allow for direct comparison to industry standards or specific comparable companies like Biogen, Eli Lilly, or Roche's R&D projects.
• The reported 6.32% stake is a substantial position for an institutional investor in a biotech company, often indicating inclusion in broad market or sector-specific index funds managed by Vanguard.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The continued significant stake by Vanguard provides a level of institutional backing. The change in Vanguard's internal reporting structure means future filings from Vanguard-affiliated entities will be disaggregated, requiring shareholders to track multiple reports for a complete picture of Vanguard's overall position.
• Investment Professionals: Will need to monitor filings from Vanguard's individual subsidiaries for a comprehensive view of their holdings in Alector Inc. post-realignment.

Next Steps

• The Vanguard Group's subsidiaries or business divisions are expected to report beneficial ownership separately (on a disaggregated basis) in future filings.

Key Dates

Keywords

Alector Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Equity Stake, Investment Management, SEC Filing